These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1918659)

  • 1. The effects of lithium discontinuation and the non-effect of oral inositol upon thyroid hormones and cortisol in patients with bipolar affective disorder.
    Souza FG; Mander AJ; Foggo M; Dick H; Shearing CH; Goodwin GM
    J Affect Disord; 1991 Jul; 22(3):165-70. PubMed ID: 1918659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy.
    Baumgartner A; von Stuckrad M; Müller-Oerlinghausen B; Gräf KJ; Kürten I
    J Affect Disord; 1995 Jun; 34(3):211-8. PubMed ID: 7560549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased motor activity and recurrent manic episodes: predictors of rapid relapse in remitted bipolar disorder patients after lithium discontinuation.
    Klein E; Lavie P; Meiraz R; Sadeh A; Lenox RH
    Biol Psychiatry; 1992 Feb; 31(3):279-84. PubMed ID: 1547301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function and psychiatric morbidity in patients with manic disorder receiving lithium therapy.
    Lee S; Chow CC; Wing YK; Shek AC; Mak TW; Ahuja A; Lee DT; Leung TY
    J Clin Psychopharmacol; 2000 Apr; 20(2):204-9. PubMed ID: 10770459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium prophylaxis of manic-depressive disorder: daily lithium dosing schedule versus every second day.
    Jensen HV; Plenge P; Mellerup ET; Davidsen K; Toftegaard L; Aggernaes H; Bjørum N
    Acta Psychiatr Scand; 1995 Jul; 92(1):69-74. PubMed ID: 7572251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional study of thyroid function in 66 patients with bipolar disorder receiving lithium for 10-44 years.
    Kraszewska A; Chlopocka-Wozniak M; Abramowicz M; Sowinski J; Rybakowski JK
    Bipolar Disord; 2015 Jun; 17(4):375-80. PubMed ID: 25359625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrupt lithium discontinuation in manic-depressive patients.
    Christodoulou GN; Lykouras EP
    Acta Psychiatr Scand; 1982 May; 65(5):310-4. PubMed ID: 6810653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function in patients maintained on lithium.
    Hatterer JA; Kocsis JH; Stokes PE
    Psychiatry Res; 1988 Dec; 26(3):249-57. PubMed ID: 3146759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.
    Frye MA; Yatham L; Ketter TA; Goldberg J; Suppes T; Calabrese JR; Bowden CL; Bourne E; Bahn RS; Adams B
    Acta Psychiatr Scand; 2009 Jul; 120(1):10-3. PubMed ID: 19183414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid function and bipolar affective disorder.
    Joffe RT; Kutcher S; MacDonald C
    Psychiatry Res; 1988 Aug; 25(2):117-21. PubMed ID: 3140257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis.
    Coppen A; Abou-Saleh M; Milln P; Bailey J; Wood K
    J Affect Disord; 1983 Nov; 5(4):353-62. PubMed ID: 6229567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: A double-blind placebo-controlled trial of levothyroxine (L-T
    Walshaw PD; Gyulai L; Bauer M; Bauer MS; Calimlim B; Sugar CA; Whybrow PC
    Bipolar Disord; 2018 Nov; 20(7):594-603. PubMed ID: 29869405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder.
    Coxhead N; Silverstone T; Cookson J
    Acta Psychiatr Scand; 1992 Feb; 85(2):114-8. PubMed ID: 1543034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder.
    Bartalena L; Pellegrini L; Meschi M; Antonangeli L; Bogazzi F; Dell'Osso L; Pinchera A; Placidi GF
    Psychiatry Res; 1990 Oct; 34(1):13-7. PubMed ID: 2125129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania.
    Kato T; Inubushi T; Takahashi S
    J Clin Psychopharmacol; 1994 Oct; 14(5):330-5. PubMed ID: 7806688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial.
    Allan SJ; Kavanagh GM; Herd RM; Savin JA
    Br J Dermatol; 2004 May; 150(5):966-9. PubMed ID: 15149510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function levels and thyrotropin responses to TRH administration in manic patients receiving lithium carbonate.
    Takahashi S; Kondo H; Yoshimura M; Ochi Y
    Folia Psychiatr Neurol Jpn; 1975; 29(3):231-7. PubMed ID: 814073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
    Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
    Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.